Drug · DIN 02537702
VYALEV
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 5, 2024; first marketed February 5, 2024.
- Drug Identification Number (DIN)
- 02537702
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Foslevodopa and decarboxylase inhibitor N04BA07
- Class
- Human
- Record last updated
- May 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FOSLEVODOPA | 240 MG | ML |
| FOSCARBIDOPA | 12 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 3, 2023: NOC 30636New Drug Submission (NDS)